Must be signed in to post a comment.
Must be signed in to post a comment.
Wed Aug 20 2025
- views
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
| Drug | Manufacturer |
|---|---|
| METOPROLOL TARTRATE | Westminster Pharmaceuticals, LLC |
16,672 1000-count bottles
Nationwide in the USA.
| UPC |
|---|
| 0369367354103 |
| NDC |
|---|
| 69367-354-10 |
| 69367-354-01 |
| 69367-355-10 |
| 69367-355-01 |
Wed Aug 20 2025
- views
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
| Drug | Manufacturer |
|---|---|
| METOPROLOL TARTRATE | Westminster Pharmaceuticals, LLC |
16,672 1000-count bottles
Nationwide in the USA.
| UPC |
|---|
| 0369367354103 |
| NDC |
|---|
| 69367-354-10 |
| 69367-354-01 |
| 69367-355-10 |
| 69367-355-01 |
Wed Aug 20 2025
- views
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
| Drug | Manufacturer |
|---|---|
| METOPROLOL TARTRATE | Westminster Pharmaceuticals, LLC |
16,672 1000-count bottles
Nationwide in the USA.
| UPC |
|---|
| 0369367354103 |
| NDC |
|---|
| 69367-354-10 |
| 69367-354-01 |
| 69367-355-10 |
| 69367-355-01 |
0 views
0 views
0 views
Comments (-)
Must be signed in to post a comment.